Cyclosporin A Attenuates the Decrease in Tyrosine Hydroxylase Immunoreactivity in Nigrostriatal Dopaminergic Neurons and in Striatal Dopamine Content in Rats with Intrastriatal Injection of 6-Hydroxydopamine
- 31 August 1997
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 146 (2) , 526-535
- https://doi.org/10.1006/exnr.1997.6575
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Protective Effect of Cyclosporin A on White Matter Changes in the Rat Brain After Chronic Cerebral HypoperfusionStroke, 1995
- Glutamatergic drugs in Parkinson's diseaseLife Sciences, 1994
- Calcineurin as a possible new target for treatment of Parkinson's diseaseMedical Hypotheses, 1994
- Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1993
- Effects of age on GM1 ganglioside-induced recovery of concentrations of dopamine in the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated miceNeuropharmacology, 1992
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- Phosphotyrosine antibodies specifically label ameboid microglia in vitro and ramified microglia in vivoGlia, 1989
- Lectin binding by resting and reactive microgliaJournal of Neurocytology, 1987
- SEVERE CENTRAL-NERVOUS-SYSTEM TOXICITY ASSOCIATED WITH CYCLOSPORINThe Lancet, 1985
- A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regionsNature, 1983